JP3862237B2 - Aerosol-type foam pack cosmetic - Google Patents
Aerosol-type foam pack cosmetic Download PDFInfo
- Publication number
- JP3862237B2 JP3862237B2 JP2000359017A JP2000359017A JP3862237B2 JP 3862237 B2 JP3862237 B2 JP 3862237B2 JP 2000359017 A JP2000359017 A JP 2000359017A JP 2000359017 A JP2000359017 A JP 2000359017A JP 3862237 B2 JP3862237 B2 JP 3862237B2
- Authority
- JP
- Japan
- Prior art keywords
- aerosol
- weight
- type foam
- stock solution
- foam pack
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006260 foam Substances 0.000 title claims description 23
- 239000002537 cosmetic Substances 0.000 title claims description 12
- -1 fatty acid esters Chemical class 0.000 claims description 18
- 239000011550 stock solution Substances 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 12
- 239000005017 polysaccharide Substances 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 10
- 239000000194 fatty acid Substances 0.000 claims description 10
- 229930195729 fatty acid Natural products 0.000 claims description 10
- 239000003380 propellant Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 150000005846 sugar alcohols Chemical class 0.000 claims description 9
- 150000002016 disaccharides Chemical class 0.000 claims description 8
- 150000002772 monosaccharides Chemical class 0.000 claims description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 230000000052 comparative effect Effects 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 206010040880 Skin irritation Diseases 0.000 description 12
- 239000000443 aerosol Substances 0.000 description 12
- 230000036556 skin irritation Effects 0.000 description 12
- 231100000475 skin irritation Toxicity 0.000 description 12
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 10
- 239000003915 liquefied petroleum gas Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 229940073490 sodium glutamate Drugs 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UCORVYFPSA-N L-ribulose Chemical compound OC[C@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-UCORVYFPSA-N 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 108010006161 conchiolin Proteins 0.000 description 2
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 2
- SXBBFOVRSQCYFE-SQKCAUCHSA-L disodium;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O SXBBFOVRSQCYFE-SQKCAUCHSA-L 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- JPLATTLXZFUKRQ-UHFFFAOYSA-N Agarobiose Natural products OCC1OC(OC2C(O)COC2C(O)C=O)C(O)C(O)C1O JPLATTLXZFUKRQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- UQPHVQVXLPRNCX-GSVOUGTGSA-N D-erythrulose Chemical compound OC[C@@H](O)C(=O)CO UQPHVQVXLPRNCX-GSVOUGTGSA-N 0.000 description 1
- ZGVNGXVNRCEBDS-HSUXUTPPSA-N D-hamamelose Chemical compound OC[C@@H](O)[C@@H](O)[C@](O)(CO)C=O ZGVNGXVNRCEBDS-HSUXUTPPSA-N 0.000 description 1
- ZGVNGXVNRCEBDS-UHFFFAOYSA-N D-hamamelose Natural products OCC(O)C(O)C(O)(CO)C=O ZGVNGXVNRCEBDS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WVZVXSGGSA-N L-xylulose Chemical compound OC[C@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-WVZVXSGGSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- NBGXQZRRLOGAJF-UHFFFAOYSA-N Maltulose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)(CO)OCC1O NBGXQZRRLOGAJF-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- BUEBVQCTEJTADB-UHFFFAOYSA-N Sambubiose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)CO1 BUEBVQCTEJTADB-UHFFFAOYSA-N 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- 150000001312 aldohexoses Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- WOHYVFWWTVNXTP-TWOHWVPZSA-N beta-D-fructofuranosyl-(2,1)-beta-D-fructofuranose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 WOHYVFWWTVNXTP-TWOHWVPZSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002574 ketohexoses Chemical class 0.000 description 1
- 150000002581 ketopentoses Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- JCQLYHFGKNRPGE-HFZVAGMNSA-N maltulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-HFZVAGMNSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- OVVGHDNPYGTYIT-PEPLWKDOSA-N robinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-PEPLWKDOSA-N 0.000 description 1
- BUEBVQCTEJTADB-IGQSMMPPSA-N sambubiose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 BUEBVQCTEJTADB-IGQSMMPPSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- DFKDOZMCHOGOBR-UHFFFAOYSA-N zaragozic acid A Natural products O1C(C(O)(C(O2)C(O)=O)C(O)=O)(C(O)=O)C(OC(=O)C=CC(C)CC(C)CC)C(O)C21CCC(=C)C(OC(C)=O)C(C)CC1=CC=CC=C1 DFKDOZMCHOGOBR-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、泡質が良好で、且つ皮膚に対し低刺激性であり、使用後の保湿性にも優れるエアゾール型の泡状パック化粧料に関する。さらに詳しくは、親水性非イオン性界面活性剤、N-アシルアミノ酸塩、糖類及び/又は糖アルコール、水溶性多糖類を含有して成る原液と、噴射剤より構成されるエアゾール型泡状パック化粧料に関する。
【0002】
【従来の技術】
エアゾール型の泡状パック化粧料は、乳化組成物中に分散した気泡膜によって外気と遮断することにより、皮膚温を上昇させ、皮膚の新陳代謝を促進する効果を有し、またピールオフ型パック化粧料のように乾燥を要しないため、パックに要する時間を自由に調節できるという利点を有する。しかしながら、使用した噴射剤に気化熱を奪われるため、使用時に皮膚表面がチクチクしたり、ヒリヒリするような刺激感が生じる点が欠点であった。
【0003】
特にオゾン層破壊の問題から、フロンガスが液化石油ガスやジメチルエーテル等他の液化ガスに代替されるに伴って、エアゾール型泡状パック化粧料における泡質の低下と皮膚刺激性の増大が認められ、製剤安定性及び使用性において問題となっていた。
【0004】
【発明が解決しようとする課題】
そこで本発明においては、噴射剤として液化石油ガスやジメチルエーテルを用いた場合においても良好な泡質を有し、さらに皮膚刺激性の低減を図ることを目的とした。
【0005】
【課題を解決するための手段】
上記の課題を解決するべく種々検討した結果、親水性非イオン性界面活性剤の1種又は2種以上、N-アシルアミノ酸塩の1種又は2種以上、単糖類,二糖類及び糖アルコールより選択した1種又は2種以上、水溶性多糖類の1種又は2種以上を併用して原液を調製し、噴射剤とともに用いることにより、エアゾール型泡状パック化粧料において泡質の向上及び皮膚刺激性の低減を図ることができ、さらに良好な保湿性が得られることを見いだし、本発明を完成するに至った。
【0006】
【発明の実施の形態】
本発明において用いる親水性の非イオン性界面活性剤としては、ポリオキシエチレングリセリル脂肪酸エステル類,ポリグリセリル脂肪酸エステル類,ポリオキシエチレンソルビタン脂肪酸エステル類,ポリオキシエチレンソルビトール脂肪酸エステル類,ポリオキシエチレンヒマシ油類,ポリオキシエチレン硬化ヒマシ油類,ポリエチレングリコール脂肪酸エステル類,ポリオキシエチレンアルキルエーテル類等で、HLB値が10程度以上のものが好ましく用いられる。これらの中でも、モノラウリン酸ヘキサグリセリル,モノミリスチン酸ヘキサグリセリル,モノラウリン酸デカグリセリル,モノミリスチン酸デカグリセリル,モノパルミチン酸デカグリセリル,モノステアリン酸デカグリセリル,モノオレイン酸デカグリセリル,モノリノール酸デカグリセリル,モノイソパルミチン酸デカグリセリル,モノイソステアリン酸デカグリセリル,ジイソパルミチン酸デカグリセリル,ジイソステアリン酸デカグリセリル等のポリグリセリル脂肪酸エステル類が特に好ましく使用できる。
【0007】
次に、本発明において用いるN-アシルアミノ酸塩としては、N-アシルグリシン,N-アシル-D-アラニン,N-アシル-DL-アラニン,N-アシル-L-アラニン,N-アシルサルコシン,N-アシル-D-アスパラギン酸,N-アシル-DL-アスパラギン酸,N-アシル-L-アスパラギン酸,N-アシル-D-グルタミン酸,N-アシル-DL-グルタミン酸,N-アシル-L-グルタミン酸等のナトリウム塩,カリウム塩,アンモニウム塩,トリエタノールアミン塩等が挙げられ、これらのアシル基としては、ラウロイル,ミリストイル,ステアロイル,ヤシ油脂肪酸アシル等が好ましい。前記N-アシルアミノ酸塩の中でも、N-ラウロイル-DL-グルタミン酸ナトリウム,N-ラウロイル-L-グルタミン酸ナトリウム,N-ミリストイル-DL-グルタミン酸ナトリウム,N-ミリストイル-L-グルタミン酸ナトリウム,N-ステアロイル-DL-グルタミン酸ナトリウム,N-ステアロイル-L-グルタミン酸ナトリウムが特に好ましく使用できる。
【0008】
続いて本発明において用い得る単糖類としては、D-エリツルロース,D-エリトロース,D-トレオース等のテトロース類、D-アラビノース,L-アラビノース,D-キシロース,D-リキソース,L-リキソース,D-リボース等のアルドペントース類、D-キシルロース,L-キシルロース,D-リブロース,L-リブロース等のケトペントース類、D-ガラクトース,L-ガラクトース,D-グルコース,D-タロース,D-マンノース等のアルドヘキソース類、L-ソルボース,D-タガトース,D-プシコース,D-フルクトース等のケトヘキソース類、D-アピオース,D-ハマメロース等の分枝糖類などが挙げられ、二糖類としては、キシロビオース,アガロビオース,カラビオース,マルトース,イソマルトース,ソホロース,セロビオース,トレハロース,ネオトレハロース,イソトレハロース,イヌロビオース,ビシアノース,イソプリメベロース,サンブビオース,プリメベロース,ソラビオース,メリビオース,ラクトース,リコビオース,エピセロビオース,スクロース,ツラノース,マルツロース,ラクツロース,エピゲンチビオース,ロビノビオース,シラノビオース,ルチノース等が挙げられ、糖アルコールとしては、エリスリトール,D-アラビトール,キシリトール,D-リビトール,ガラクチトール,D-グルシトール,D-マンニトール,マルチトール等が挙げられる。これらの中でも、スクロース,マルトース及びD-グルシトールが特に好ましく使用できる。
【0009】
また、本発明において用い得る水溶性多糖類としては、グアーガム,ローカストビーンガム,クインスシード,カラギーナン,ガラクタン,アラビアガム,トラガカントガム,ペクチン,マンナン,デンプン等の植物系多糖類、キサンタンガム,デキストラン,サクシノグルカン,カードラン等の微生物系多糖類、ヒドロキシエチルセルロース,ヒドロキシプロピルセルロース,カルボキシメチルセルロースナトリウム,メチルヒドロキシプロピルセルロース,可溶性デンプン,カルボキシメチルデンプン,アルギン酸ナトリウム,アルギン酸プロピレングリコールエステル等の多糖類誘導体などが挙げられる。これらの中でも、カラギーナン,キサンタンガム,アルギン酸ナトリウム,カルボキシメチルセルロースナトリウムが特に好ましく使用できる。
【0010】
本発明においては、上記した親水性非イオン性界面活性剤の1種又は2種以上、N-アシルアミノ酸塩の1種又は2種以上、単糖類,二糖類及び糖アルコールより選択した1種又は2種以上、水溶性多糖類の1種又は2種以上を併用して原液を調製し、噴射剤とともにエアゾール缶に充填する。原液中における親水性非イオン性界面活性剤の1種又は2種以上、N-アシルアミノ酸塩の1種又は2種以上、単糖類,二糖類及び糖アルコールより選択した1種又は2種以上、水溶性多糖類の1種又は2種以上の各含有量としては、5.0〜7.0重量%、1.0〜3.0重量%、5.0〜15.0重量%、0.05〜0.3重量%とするのが好ましい。
【0011】
噴射剤としては、液化石油ガス又は液化石油ガスとジメチルエーテルを併用して用いることが好ましい。原液と噴射剤との混合量比は、93:7〜97:3とするのが好ましい。
【0012】
なお本発明に係るエアゾール型泡状パック化粧料には、本発明の特徴を損なわない範囲で、油性成分,他の界面活性剤,保湿剤,紫外線吸収剤,抗酸化剤,香料,防菌防黴剤等の一般的な医薬品及び化粧料用原料や、ビタミン類,タンパク質加水分解物等の皮膚細胞賦活剤,抗炎症剤,美白剤等の生理活性成分をも含有させることができる。
【0013】
【実施例】
さらに本発明の特徴について、実施例により詳細に説明する。
【0014】
本発明に係る実施例1〜実施例3の処方を表1に示す。また、これらに対する比較例1〜比較例3の処方を表2に示す。原液の調製方法としては、表1及び表2中のA成分を混合して75℃に加熱し、あらかじめ混合,溶解して75℃に加熱したB成分に加えてホモミキサーにて乳化し、冷却して得る。エアゾール剤は、表1及び表2中のC成分をエアゾール缶に充填した後、バルブを装着してD成分を充填して調製する。
【0015】
【表1】
【0016】
【表2】
【0017】
続いて、本発明に係る他の実施例の処方を示す。
【0018】
[実施例4]
原液:
(1)スクワラン 5.00(重量%)
(2)アボカド油 1.00
(3)β-カロテン 0.01
(4)1,3-ブチレングリコール 3.50
(5)グリセリン 30.00
(6)モノミリスチン酸デカグリセリル 6.00
(7)N-ラウロイル-L-グルタミン酸ナトリウム 1.50
(8)マルトース 15.00
(9)キサンタンガム 0.10
(10)パラオキシ安息香酸メチル 0.10
(11)精製水 37.69
(12)香料 0.10
製法:(1)〜(3)の油相成分を混合,加熱し、75℃とする。一方、(4)〜(11)を混合,溶解して75℃に加熱し、前記油相成分を添加してホモミキサーにて乳化し、冷却後40℃にて(12)を添加,混合する。
エアゾール:
(1)原液 97.0(重量%)
(2)液化石油ガス 3.0
製法:エアゾール缶に(1)を充填した後、バルブを装着して、(2)を充填する。
【0019】
[実施例5]
原液:
(1)流動パラフィン 4.50(重量%)
(2)セタノール 1.00
(3)グリセリン 35.00
(4)モノパルミチン酸デカグリセリル 5.50
(5)N-ミリストイル-L-グルタミン酸ナトリウム 2.50
(6)D-グルシトール 12.50
(7)アルギン酸ナトリウム 0.20
(8)コンキオリン加水分解物 0.02
(9)パラオキシ安息香酸メチル 0.10
(10)精製水 38.58
(11)香料 0.10
製法:(1),(2)の油相成分を混合,加熱し、75℃とする。一方、(3)〜(10)を混合,溶解して75℃に加熱し、前記油相成分を添加してホモミキサーにて乳化し、冷却後40℃にて(11)を添加,混合する。
エアゾール:
(1)原液 95.0(重量%)
(2)液化石油ガス 5.0
製法:エアゾール缶に(1)を充填した後、バルブを装着して、(2)を充填する。
【0020】
[実施例6]
原液:
(1)スクワラン 2.50(重量%)
(2)ベヘニルアルコール 4.00
(3)グリセリン 35.00
(4)モノステアリン酸デカグリセリル 6.50
(5)N-ステアロイル-L-グルタミン酸ナトリウム 2.50
(6)マルチトール 5.00
(7)スクロース 2.50
(8)カルボキシメチルセルロースナトリウム 0.30
(9)パラオキシ安息香酸メチル 0.10
(10)精製水 41.48
(11)ホエイ(乳清) 0.02
(12)香料 0.10
製法:(1),(2)の油相成分を混合,加熱し、75℃とする。一方、(3)〜(10)を混合,溶解して75℃に加熱し、前記油相成分を添加してホモミキサーにて乳化し、冷却後40℃にて(11),(12)を添加,混合する。
エアゾール:
(1)原液 94.0(重量%)
(2)液化石油ガス 4.2
(3)ジメチルエーテル 1.8
製法:エアゾール缶に(1)を充填した後、バルブを装着して、(2),(3)を充填する。
【0021】
[実施例7]
原液:
(1)ベヘニルアルコール 4.00(重量%)
(2)ホホバ油 1.00
(3)β-カロテン 0.01
(4)1,3-ブチレングリコール 5.00
(5)グリセリン 32.50
(6)モノラウリン酸デカグリセリル 5.00
(7)モノラウリン酸ヘキサグリセリル 1.00
(8)N-ステアロイル-L-グルタミン酸ナトリウム 2.00
(9)マルトース 12.50
(10)キサンタンガム 0.05
(11)カラギーナン 0.05
(12)コンキオリン加水分解液 0.01
(13)パラオキシ安息香酸メチル 0.10
(14)精製水 36.68
(15)香料 0.10
製法:(1)〜(3)の油相成分を混合,加熱し、75℃とする。一方、(4)〜(14)を混合,溶解して75℃に加熱し、前記油相成分を添加してホモミキサーにて乳化し、冷却後40℃にて(15)を添加,混合する。
エアゾール:
(1)原液 96.0(重量%)
(2)液化石油ガス 2.8
(3)ジメチルエーテル 1.2
製法:エアゾール缶に(1)を充填した後、バルブを装着して、(2),(3)を充填する。
【0022】
また、上記実施例4において、モノミリスチン酸デカグリセリル及びN-ラウロイル-L-グルタミン酸ナトリウムをステアリン酸7.0重量%及び水酸化カリウム0.35重量%に代替し、精製水で全量を100.0重量%とした原液を用いたものを比較例4、実施例5において、モノパルミチン酸デカグリセリル及びN-ミリストイル-L-グルタミン酸ナトリウムをポリオキシエチレン(20E.O.)セチルエーテル5.0重量%に代替し、精製水で全量を100.0重量%とした原液を用いたものを比較例5、実施例6において、マルチトール及びスクロースをグリセリンに代替したものを比較例6、実施例7において、キサンタンガム及びカラギーナンを精製水に代替したものを比較例7とした。
【0023】
上記実施例1〜実施例7及び比較例1〜比較例7について、泡質,皮膚刺激性及び使用後の保湿性について評価した。これらの評価は、20才代〜50才代の女性パネラー20名を1群とし、各群に実施例及び比較例をそれぞれブラインドにて使用させ、官能評価させて行った。評価結果は、表3に示す評価基準に従って点数化し、20名の平均値を算出して表4に示した。
【0024】
【表3】
【0025】
【表4】
【0026】
表4より明らかなように、本発明の実施例1〜実施例7については、ほぼ良好,もしくは良好な泡質が認められており、皮膚刺激性についても微妙に感じられる程度で、明らかな低減が見られていた。また使用後には、高い保湿性が認められていた。
【0027】
これに対し、界面活性剤として脂肪酸セッケンを用い、単糖類,二糖類及び糖アルコールより選択される1種又は2種以上及び水溶性多糖類を含有しない比較例1〜比較例3のうち、噴射剤の配合量が少ない比較例1では、皮膚刺激性はさほど認められていないものの、良好な泡質は得られていなかった。比較例1より噴射剤を増量した比較例2では泡質の改善は見られていたが、皮膚刺激性の増大が認められ、グリセリンを増量した比較例3においても、皮膚刺激性の低減は見られていなかった。また、親水性非イオン性界面活性剤及びN-アシルアミノ酸塩を脂肪酸セッケン又はポリオキシエチレン付加型のアルキルエーテルのみに代替した比較例4及び比較例5では、かなりの皮膚刺激性が認められていた。単糖類,二糖類及び糖アルコールより選択される1種又は2種以上をグリセリンに代替した比較例6においても、明確な皮膚刺激性が認められており、水溶性多糖類を含有しない比較例7においては、泡質の低下が見られていた。さらに、単糖類,二糖類及び糖アルコールより選択される1種又は2種以上を含有しない比較例1〜比較例3及び比較例6では、特に保湿性の評価がそれぞれ対応する実施例に比べて低くなっていた。
【0028】
なお本発明の実施例については、25℃で6カ月間保存した場合においても、泡質の低下や析出物の出現等の状態の変化は全く認められず、バルブの詰まりなども生じなかった。また、男性パネラー30名を用いた48時間の背部皮膚閉塞貼付試験においても、問題となる皮膚刺激性反応は認められなかった。
【0029】
【発明の効果】
以上詳述したように、本発明により、泡質が良好で、且つ皮膚に対し低刺激性であり、使用後の保湿性にも優れるエアゾール型の泡状パック化粧料を得ることができた。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an aerosol-type foam pack cosmetic that has good foam quality, low skin irritation, and excellent moisture retention after use. More specifically, an aerosol-type foam pack makeup comprising a stock solution containing a hydrophilic nonionic surfactant, an N-acylamino acid salt, a saccharide and / or a sugar alcohol, a water-soluble polysaccharide, and a propellant. Regarding fees.
[0002]
[Prior art]
Aerosol-type foam pack cosmetics have the effect of increasing the skin temperature and promoting the metabolism of the skin by blocking the outside air by the bubble film dispersed in the emulsified composition, and the peel-off type pack cosmetics Thus, since drying is not required, the time required for packing can be freely adjusted. However, since the propellant used is deprived of the heat of vaporization, there is a drawback in that the skin surface is tinged or irritated during use.
[0003]
In particular, due to the problem of ozone layer destruction, as chlorofluorocarbon gas is replaced by other liquefied gas such as liquefied petroleum gas and dimethyl ether, a decrease in foam quality and an increase in skin irritation in aerosol type foam pack cosmetics are recognized, It has been a problem in formulation stability and usability.
[0004]
[Problems to be solved by the invention]
Therefore, the present invention has an object to have good foam quality even when liquefied petroleum gas or dimethyl ether is used as a propellant and to further reduce skin irritation.
[0005]
[Means for Solving the Problems]
As a result of various studies to solve the above problems, one or more hydrophilic nonionic surfactants, one or more N-acylamino acid salts, monosaccharides, disaccharides and sugar alcohols 1 type or 2 types or more selected, 1 type or 2 types or more of water-soluble polysaccharides are used in combination to prepare an undiluted solution and use it together with a propellant to improve the foam quality and the skin in aerosol-type foam pack cosmetics It has been found that the irritation can be reduced and that a better moisturizing property can be obtained, and the present invention has been completed.
[0006]
DETAILED DESCRIPTION OF THE INVENTION
Examples of the hydrophilic nonionic surfactant used in the present invention include polyoxyethylene glyceryl fatty acid esters, polyglyceryl fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene sorbitol fatty acid esters, polyoxyethylene castor oil Of these, polyoxyethylene hydrogenated castor oils, polyethylene glycol fatty acid esters, polyoxyethylene alkyl ethers and the like having an HLB value of about 10 or more are preferably used. Among these, hexaglyceryl monolaurate, hexaglyceryl monomyristate, decaglyceryl monolaurate, decaglyceryl monomyristate, decaglyceryl monopalmitate, decaglyceryl monostearate, decaglyceryl monooleate, decaglyceryl monolinoleate, Polyglyceryl fatty acid esters such as deisoglyceryl monoisopalmitate, decaglyceryl monoisostearate, decaglyceryl diisopalmitate, decaglyceryl diisostearate can be particularly preferably used.
[0007]
Next, N-acylamino acid salts used in the present invention include N-acylglycine, N-acyl-D-alanine, N-acyl-DL-alanine, N-acyl-L-alanine, N-acylsarcosine, N -Acyl-D-aspartic acid, N-acyl-DL-aspartic acid, N-acyl-L-aspartic acid, N-acyl-D-glutamic acid, N-acyl-DL-glutamic acid, N-acyl-L-glutamic acid, etc. Sodium salts, potassium salts, ammonium salts, triethanolamine salts, and the like. As these acyl groups, lauroyl, myristoyl, stearoyl, coconut oil fatty acid acyl and the like are preferable. Among the N-acyl amino acid salts, N-lauroyl-DL-sodium glutamate, N-lauroyl-L-sodium glutamate, N-myristoyl-DL-sodium glutamate, N-myristoyl-L-sodium glutamate, N-stearoyl-DL -Sodium glutamate and sodium N-stearoyl-L-glutamate can be particularly preferably used.
[0008]
Subsequently, monosaccharides that can be used in the present invention include D-erythrulose, D-erythrose, tetrose such as D-threose, D-arabinose, L-arabinose, D-xylose, D-lyxose, L-lyxose, D- Aldopentoses such as ribose, ketopentoses such as D-xylulose, L-xylulose, D-ribulose and L-ribulose, aldohexoses such as D-galactose, L-galactose, D-glucose, D-talose and D-mannose , L-sorbose, D-tagatose, D-psicose, ketohexoses such as D-fructose, and branched sugars such as D-apiose and D-hamamelose. Disaccharides include xylobiose, agarobiose, and carabiose. , Maltose, isomaltose, sophorose, cellobiose, trehalose, neotrehalose, isotreha Sucrose, inulobiose, vicyanose, isoprimebellose, sambubiose, primebellose, sorabiose, melibiose, lactose, lycobiose, epicellobiose, sucrose, tulanose, maltulose, lactulose, epigenbiose, robinobiose, silanobiose, lutinose, etc. Examples of the sugar alcohol include erythritol, D-arabitol, xylitol, D-ribitol, galactitol, D-glucitol, D-mannitol, maltitol and the like. Among these, sucrose, maltose and D-glucitol can be particularly preferably used.
[0009]
Examples of water-soluble polysaccharides that can be used in the present invention include guar gum, locust bean gum, quince seed, carrageenan, galactan, arabic gum, tragacanth gum, pectin, mannan, starch and other plant polysaccharides, xanthan gum, dextran, succino Examples include microbial polysaccharides such as glucan and curdlan, polysaccharide derivatives such as hydroxyethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, methylhydroxypropylcellulose, soluble starch, carboxymethyl starch, sodium alginate, propylene glycol alginate, etc. . Among these, carrageenan, xanthan gum, sodium alginate, and sodium carboxymethyl cellulose can be particularly preferably used.
[0010]
In the present invention, one or more of the above-described hydrophilic nonionic surfactants, one or more of N-acylamino acid salts, one or more selected from monosaccharides, disaccharides and sugar alcohols A stock solution is prepared by using one or more water-soluble polysaccharides, or two or more water-soluble polysaccharides together, and filled into an aerosol can together with a propellant. One or more hydrophilic nonionic surfactants in the stock solution, one or more N-acylamino acid salts, one or more selected from monosaccharides, disaccharides and sugar alcohols, As each content of 1 type or 2 types or more of water-soluble polysaccharide, it is 5.0 to 7.0 weight%, 1.0 to 3.0 weight%, 5.0 to 15.0 weight%, 0.0. It is preferable to set it as 05 to 0.3 weight%.
[0011]
As the propellant, liquefied petroleum gas or liquefied petroleum gas and dimethyl ether are preferably used in combination. The mixing ratio of the stock solution and the propellant is preferably 93: 7 to 97: 3.
[0012]
The aerosol-type foam pack cosmetic according to the present invention includes oily components, other surfactants, moisturizers, ultraviolet absorbers, antioxidants, perfumes, antibacterial and antimicrobial agents, as long as the characteristics of the present invention are not impaired. Raw materials for general pharmaceuticals and cosmetics such as glazes, and physiologically active ingredients such as skin cell activators such as vitamins and protein hydrolysates, anti-inflammatory agents, and whitening agents can also be included.
[0013]
【Example】
Further, the features of the present invention will be described in detail with reference to examples.
[0014]
The formulations of Examples 1 to 3 according to the present invention are shown in Table 1. Table 2 shows the formulations of Comparative Examples 1 to 3 for these. As a method for preparing the stock solution, the components A in Table 1 and Table 2 are mixed and heated to 75 ° C, mixed and dissolved in advance and added to the component B heated to 75 ° C, emulsified with a homomixer, and cooled. And get. The aerosol agent is prepared by filling the aerosol can with the component C in Tables 1 and 2 and then filling the component D with a valve.
[0015]
[Table 1]
[0016]
[Table 2]
[0017]
Then, the prescription of the other Example which concerns on this invention is shown.
[0018]
[Example 4]
Stock solution:
(1) Squalane 5.00 (wt%)
(2) Avocado oil 1.00
(3) β-carotene 0.01
(4) 1,3-butylene glycol 3.50
(5) Glycerin 30.00
(6) Decaglyceryl monomyristate 6.00
(7) Sodium N-lauroyl-L-glutamate 1.50
(8) Maltose 15.00
(9) Xanthan gum 0.10
(10) Methyl paraoxybenzoate 0.10
(11) Purified water 37.69
(12) Fragrance 0.10
Production method: The oil phase components (1) to (3) are mixed and heated to 75 ° C. On the other hand, (4) to (11) are mixed, dissolved and heated to 75 ° C., the oil phase component is added and emulsified with a homomixer, and after cooling, (12) is added and mixed at 40 ° C. .
aerosol:
(1) Stock solution 97.0 (% by weight)
(2) Liquefied petroleum gas 3.0
Manufacturing method: After filling (1) into an aerosol can, attach a valve and fill (2).
[0019]
[Example 5]
Stock solution:
(1) Liquid paraffin 4.50 (wt%)
(2) Cetanol 1.00
(3) Glycerin 35.00
(4) Decaglyceryl monopalmitate 5.50
(5) Sodium N-myristoyl-L-glutamate 2.50
(6) D-glucitol 12.50
(7) Sodium alginate 0.20
(8) Conchiolin hydrolyzate 0.02
(9) Methyl paraoxybenzoate 0.10
(10) Purified water 38.58
(11) Fragrance 0.10
Production method: The oil phase components (1) and (2) are mixed and heated to 75 ° C. On the other hand, (3) to (10) are mixed, dissolved and heated to 75 ° C., the oil phase component is added and emulsified with a homomixer, and after cooling, (11) is added and mixed at 40 ° C. .
aerosol:
(1) Stock solution 95.0 (% by weight)
(2) Liquefied petroleum gas 5.0
Manufacturing method: After filling (1) into an aerosol can, attach a valve and fill (2).
[0020]
[Example 6]
Stock solution:
(1) Squalane 2.50 (wt%)
(2) Behenyl alcohol 4.00
(3) Glycerin 35.00
(4) Decaglyceryl monostearate 6.50
(5) N-stearoyl-L-glutamate sodium 2.50
(6) Maltitol 5.00
(7) Sucrose 2.50
(8) Sodium carboxymethylcellulose 0.30
(9) Methyl paraoxybenzoate 0.10
(10) Purified water 41.48
(11) Whey (whey) 0.02
(12) Fragrance 0.10
Production method: The oil phase components (1) and (2) are mixed and heated to 75 ° C. On the other hand, (3) to (10) are mixed, dissolved and heated to 75 ° C., the oil phase component is added and emulsified with a homomixer, and after cooling, (11) and (12) are added at 40 ° C. Add and mix.
aerosol:
(1) Stock solution 94.0 (wt%)
(2) Liquefied petroleum gas 4.2
(3) Dimethyl ether 1.8
Manufacturing method: After filling (1) into an aerosol can, attach a valve and fill (2) and (3).
[0021]
[Example 7]
Stock solution:
(1) Behenyl alcohol 4.00 (wt%)
(2) Jojoba oil 1.00
(3) β-carotene 0.01
(4) 1,3-butylene glycol 5.00
(5) Glycerin 32.50
(6) Decaglyceryl monolaurate 5.00
(7) Hexaglyceryl monolaurate 1.00
(8) Sodium N-stearoyl-L-glutamate 2.00
(9) Maltose 12.50
(10) Xanthan gum 0.05
(11) Carrageenan 0.05
(12) Conchiolin hydrolyzed solution 0.01
(13) Methyl paraoxybenzoate 0.10
(14) Purified water 36.68
(15) Fragrance 0.10
Production method: The oil phase components (1) to (3) are mixed and heated to 75 ° C. On the other hand, (4) to (14) are mixed, dissolved and heated to 75 ° C., the oil phase component is added and emulsified with a homomixer, and after cooling, (15) is added and mixed at 40 ° C. .
aerosol:
(1) Stock solution 96.0 (wt%)
(2) Liquefied petroleum gas 2.8
(3) Dimethyl ether 1.2
Manufacturing method: After filling (1) into an aerosol can, attach a valve and fill (2) and (3).
[0022]
In Example 4 above, decaglyceryl monomyristate and sodium N-lauroyl-L-glutamate were replaced with 7.0% by weight stearic acid and 0.35% by weight potassium hydroxide, and the total amount was 100.000 with purified water. In Comparative Example 4 and Example 5 using 0% by weight undiluted solution, decaglyceryl monopalmitate and sodium N-myristoyl-L-glutamate were mixed with 5.0% polyoxyethylene (20E.O.) cetyl ether. In Comparative Example 5 and Example 6 using a stock solution whose total amount was 100.0% by weight with purified water, Comparative Example 6 and Example 7 were used in which maltitol and sucrose were replaced with glycerin. In Comparative Example 7, xanthan gum and carrageenan were replaced with purified water.
[0023]
About the said Example 1- Example 7 and Comparative Example 1- Comparative Example 7, foam quality, skin irritation, and moisture retention after use were evaluated. These evaluations were performed by grouping 20 female panelists in their 20s to 50s into groups, and using each of the examples and comparative examples blindly in each group for sensory evaluation. The evaluation results were scored according to the evaluation criteria shown in Table 3, and the average value of 20 people was calculated and shown in Table 4.
[0024]
[Table 3]
[0025]
[Table 4]
[0026]
As is apparent from Table 4, in Examples 1 to 7 of the present invention, almost good or good foam quality is recognized, and the skin irritation is subtly felt, and it is clearly reduced. Was seen. Moreover, after use, high moisture retention was recognized.
[0027]
On the other hand, among the Comparative Examples 1 to 3, which uses fatty acid soap as a surfactant and does not contain one or more selected from monosaccharides, disaccharides and sugar alcohols, and water-soluble polysaccharides, injection In Comparative Example 1 where the blending amount of the agent was small, although no skin irritation was observed, good foam quality was not obtained. In Comparative Example 2 in which the amount of propellant was increased from Comparative Example 1, foam quality was improved, but an increase in skin irritation was observed, and in Comparative Example 3 in which the amount of glycerin was increased, a decrease in skin irritation was also observed. It was not done. In Comparative Example 4 and Comparative Example 5 in which the hydrophilic nonionic surfactant and the N-acyl amino acid salt were replaced with only fatty acid soap or polyoxyethylene-added alkyl ether, considerable skin irritation was observed. It was. In Comparative Example 6 in which one or more selected from monosaccharides, disaccharides, and sugar alcohols are replaced with glycerin, clear skin irritation is recognized, and Comparative Example 7 does not contain a water-soluble polysaccharide. In, the foam quality was lowered. Furthermore, in Comparative Examples 1 to 3 and Comparative Example 6 that do not contain one or more selected from monosaccharides, disaccharides, and sugar alcohols, the moisturizing evaluation is particularly compared to the corresponding examples. It was low.
[0028]
In the examples of the present invention, even when stored at 25 ° C. for 6 months, no change in state such as deterioration of foam quality or appearance of precipitates was observed, and no valve clogging occurred. In a 48-hour dorsal skin occlusion test using 30 male panelists, no problematic skin irritation reaction was observed.
[0029]
【The invention's effect】
As described above in detail, according to the present invention, an aerosol-type foam pack cosmetic with good foam quality, low skin irritation and excellent moisture retention after use can be obtained.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000359017A JP3862237B2 (en) | 2000-11-27 | 2000-11-27 | Aerosol-type foam pack cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000359017A JP3862237B2 (en) | 2000-11-27 | 2000-11-27 | Aerosol-type foam pack cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002161022A JP2002161022A (en) | 2002-06-04 |
| JP3862237B2 true JP3862237B2 (en) | 2006-12-27 |
Family
ID=18830848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000359017A Expired - Fee Related JP3862237B2 (en) | 2000-11-27 | 2000-11-27 | Aerosol-type foam pack cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3862237B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4576171B2 (en) * | 2004-07-23 | 2010-11-04 | 株式会社ファンケル | Difractose anhydride-containing topical skin preparation |
| JP4782634B2 (en) * | 2006-08-02 | 2011-09-28 | 花王株式会社 | Aerosol pack cosmetic |
| JP5658879B2 (en) * | 2009-10-01 | 2015-01-28 | 花王株式会社 | Aerosol skin cosmetics |
| JP6831996B2 (en) * | 2016-10-21 | 2021-02-24 | 株式会社バスクリン | Aerosol type foam pack cosmetics |
| JP7018344B2 (en) * | 2018-03-30 | 2022-02-10 | 株式会社コーセー | Foam cosmetics |
| JP7511407B2 (en) * | 2019-12-05 | 2024-07-05 | 株式会社コーセー | Hair cosmetics |
-
2000
- 2000-11-27 JP JP2000359017A patent/JP3862237B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002161022A (en) | 2002-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2167647C2 (en) | Shaving composition in form of self-foaming gel | |
| ES2378383T3 (en) | Foam product for self-heating shave | |
| EP0586929B1 (en) | Hair treatment composition and process | |
| ES2843905T3 (en) | Oil-in-water emulsion and cosmetic use thereof | |
| JP5995233B2 (en) | Foam aerosol composition | |
| US4617185A (en) | Improved deodorant stick | |
| JP3922299B2 (en) | Thickening composition | |
| GB2129683A (en) | Cosmetic sticks | |
| JP2001509798A (en) | A cleansing composition comprising a separately removed cleansing base and an effective base, wherein the effective base also comprises a surfactant. | |
| JPH10513179A (en) | Roll-on antiperspirant composition | |
| JP2002533564A (en) | Cleaning composition | |
| JP5808709B2 (en) | Foam aerosol composition | |
| JP5775671B2 (en) | Aerosol-type cosmetics | |
| JP3862237B2 (en) | Aerosol-type foam pack cosmetic | |
| JP6076080B2 (en) | Foam lotion | |
| JP3421018B2 (en) | Whipped O / W type emulsified cosmetic and method for producing the same | |
| JP5658879B2 (en) | Aerosol skin cosmetics | |
| ES2329600T3 (en) | COSMETIC COMPOSITIONS ABLE TO FOAM. | |
| JPH0618768B2 (en) | Solid powder cosmetics | |
| JPH10306276A (en) | Temperature-sensitive composition, temperature-sensitive composition for aerosol and temperature-sensitive aerosol product | |
| CN113332174A (en) | Liquid crystal emulsified system amino acid skin cleaning cream and preparation method thereof | |
| JP7595119B2 (en) | Oil-in-water emulsion composition and method for producing same | |
| JP2013237615A (en) | Foam aerosol composition | |
| ES2399896T3 (en) | Shaving product of non-self-heating spray type | |
| JP2806033B2 (en) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040129 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040324 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040531 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060923 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091006 Year of fee payment: 3 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D05 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091006 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101006 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101006 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111006 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111006 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121006 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121006 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131006 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |